5
Views
8
CrossRef citations to date
0
Altmetric
PROLACTIN EXCESS

Hyperprolactinemia

Causes, consequences, and treatment options

Pages 265-268 | Published online: 05 Dec 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Aslihan Polat, Hatice Turan & Ugur Cakir. (2014) Late-Onset Normoprolactinemic Galactorrhea Associated with Fluoxetine Use: a Case Report. Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology 24:3, pages 265-267.
Read now
Sencan Sertcelik, Bahadir Bakim & Oguz Karamustafalioglu. (2012) High Dose Paroxetine-Induced Galactorrhea with Normal Serum Prolactin Level: A case report. Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology 22:4, pages 355-356.
Read now

Articles from other publishers (6)

Soo Jin Yun, Hyunji Sang, So Young Park & Sang Ouk Chin. (2024) Effect of Hyperprolactinemia on Bone Metabolism: Focusing on Osteopenia/Osteoporosis. International Journal of Molecular Sciences 25:3, pages 1474.
Crossref
Amin Abdollahzade FardPeiman AbbasnezhadKhadijeh MakhdomiMorteza SalehiHamid Reza KaramdelEhsan Saboory. (2017) Association of Serum Prolactin Concentrations with Renal Failure in Diabetic Patients. Romanian Journal of Diabetes Nutrition and Metabolic Diseases 24:3, pages 179-185.
Crossref
Paul. Terranova. 2017. Reference Module in Biomedical Sciences. Reference Module in Biomedical Sciences.
William E. Winter, Ishwarlal Jialal, Mary Lee Vance & Roger L. Bertholf. 2012. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics 1803 1845 .
Frank Nawroth. (2005) Hyperprolactinaemia and the regular menstrual cycle in asymptomatic women: should it be treated during therapy for infertility?. Reproductive BioMedicine Online 11:5, pages 581-588.
Crossref
Montserrat Vera-Llonch, Thomas E. Delea, Erin Richardson, Marcia Rupnow, Amy Grogg & Gerry Oster. (2004) Outcomes and Costs of Risperidone versus Olanzapine in Patients with Chronic Schizophrenia or Schizoaffective Disorders: A Markov Model. Value in Health 7:5, pages 569-584.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.